Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA:600566)

Market Cap	24.42B
Revenue (ttm)	7.14B
Net Income (ttm)	2.13B
Shares Out	920.66M
EPS (ttm)	2.32
PE Ratio	11.43
Forward PE	11.33
Dividend	2.09 (7.86%)
Ex-Dividend Date	Jun 30, 2025

Volume	7,410,570
Average Volume	8,126,230
Open	26.59
Previous Close	26.59
Day's Range	26.40 - 26.61
52-Week Range	23.85 - 34.46
Beta	0.09
RSI	42.85
Earnings Date	Aug 23, 2025

About SHA:600566

Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based Chinese traditional medicines, and Chinese medicine health products in China. The company offers Chinese and western medicines in the areas of pediatrics, gynecology, pneumology, gastroenterology, neurology, and geriatrics; oral and skin care products; and anti-fatigue, anti-aging, antioxidant, and immunity-enhancing Chinese medicine health products. It also develop...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Fei Cao
• Employees: 5,026
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600566

Financial Performance

In 2024, SHA:600566's revenue was 8.02 billion, a decrease of -16.96% compared to the previous year's 9.65 billion. Earnings were 2.53 billion, a decrease of -10.32%.